Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
137M
-
Number of holders
-
206
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
-3.82M
-
Total reported value, excl. options
-
$611M
-
Value change
-
-$20.2M
-
Put/Call ratio
-
0.53
-
Number of buys
-
85
-
Number of sells
-
-104
-
Price
-
$5.71
Significant Holders of Vir Biotechnology, Inc. - Common Stock (VIR) as of Q3 2025
246 filings reported holding VIR - Vir Biotechnology, Inc. - Common Stock as of Q3 2025.
Vir Biotechnology, Inc. - Common Stock (VIR) has 206 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
of 137M outstanding shares and own 77.94% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (16.7M shares), BlackRock, Inc. (16M shares), ARCH Venture Management, LLC (12.9M shares), VANGUARD GROUP INC (12.8M shares), STATE STREET CORP (5.24M shares), FMR LLC (3.64M shares), DIMENSIONAL FUND ADVISORS LP (2.98M shares), MORGAN STANLEY (2.69M shares), ORBIMED ADVISORS LLC (2.38M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.25M shares).
This table shows the top 206 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.